8502 ORAL Phase II Study of RAD001 Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma

First Page		Document Content
Date: 2013-10-17 15:53:11 Anatomical pathology Carcinoma Gastrointestinal cancer Gynaecological cancer Squamous-cell carcinoma Adenoid cystic carcinoma Head and neck cancer Laryngeal cancer Vascular endothelial growth factor Medicine Oncology Lung cancer		8502 ORAL Phase II Study of RAD001 Monotherapy in Patients With Unresectable Adenoid Cystic Carcinoma Add to Reading List Source URL: www.accrf.org Download Document from Source Website File Size: 39,62 KB Share Document on Facebook

	DEPARTMENT OF PATHOLOGY University at Buffalo Pathology Residency Program Description and Overview Program: Four Year Combined Anatomic and Clinical Pathology The 4-year combined Anatomic/Clinical Pathology training prog DocID: 1rnhv - View Document
	Microsoft Word - MALIGNANT MELANOMA IN DOGS_Link to Melanoma.doc DocID: 1re0z - View Document
	THE ESSENTIALS OF LIFE SCIENCE RESEARCH GLOBALLY DELIVERED™ LUNG TUMOR CELL LINES DocID: 1rdDi - View Document
	ABP BOOKLET OF INFORMATION Questions remaining after review of this document may be addressed to Rebecca L. Johnson, M.D., Chief Executive Officer at , Mary Pyfrom, Coordinator of Primary Application DocID: 1rbpS - View Document
	SURGICAL PATHOLOGY FELLOWSHIP (July 2016 and JulyThe Department of Pathology and Laboratory Medicine at UC Irvine Medical Center offers a 1-year in depth SURGICAL PATHOLOGY FELLOWSHIP that provides an intense and DocID: 1raNK - View Document